Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Formela Jean Francois
Relationship:  
City:   Waltham
State:   MA
   
Insider Summary:
  
   
Companies Owned :   13    
Direct Shares   7,291    

Indirect Shares

   24,762,873      
Direct Value   $155,882    

Indirect Value

   $272,924,216      
Total Shares   24,770,164      
Total Value   $273,080,098      


Intellia Therapeutics, Inc. $155,882 Intellia Therapeutics, Inc. $155,882
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    4    

     Stock price went up :
    0   
    4    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   4.0   
     Percentage Gain/Loss :
     0.0%
 179.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Decode Genetics Inc DCGN Director 2003-09-09 0 2003-12-11 0    Premium*  
            Exelixis Inc EXEL Director 2003-11-13 0 2005-09-07 584,519    Premium*  
            Nxstage Medical, Inc. NXTM Director, 10% Owner 0 2006-05-26 2,592,126    Premium*  
            Sgx Pharmaceuticals, Inc. SGXP Director, 10% Owner 2006-02-01 0 2006-02-06 2,485,068    Premium*  
            Achillion Pharmaceuticals Inc ACHN Director, 10% Owner 2006-10-31 0 2006-10-31 1,968,670    Premium*  
            Nuvelo Inc ABIO Director, 10% Owner 0 2012-10-22 1,579,542    Premium*  
            Horizon Pharma, Inc. HZNP Director, 10% Owner 0 2011-08-02 5,393,178    Premium*  
            Egalet Corp EGLT Director, 10% Owner 0 2014-02-11 2,460,949    Premium*  
            Intellia Therapeutics, Inc. NTLA Director 2022-06-14 7,291 2021-06-28 10,000    Premium*  
            Spero Therapeutics Inc SPRO Director 2017-11-06 0 2017-11-06 2,408,128    Premium*  
            Translate Bio, Inc. TBIO Director 2018-07-02 0 2021-09-14 0    Premium*  
            Ikena Oncology, Inc. IKNA Director 0 2021-12-14 4,143,544    Premium*  
            Korro Bio KRRO 2023-11-03 0 2024-04-22 1,137,149    Premium*  
* Premium Members only  

Records found :    96         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
DCGN Decode Genetics Inc Director   –       •      –    2003-09-25 4 D $18.00 $250,020 I/I (13,890) 125,846 -
DCGN Decode Genetics Inc Director   –       •      –    2003-09-25 4 OE $1.00 $250,000 I/I 250,000 132,791 -
DCGN Decode Genetics Inc Director   –       •      –    2003-09-26 4 S $4.22 $280,956 I/I (66,500) 72,305 -
DCGN Decode Genetics Inc Director   –       •      –    2003-09-30 4 S $4.91 $490,760 I/I (100,000) 22,305 -
DCGN Decode Genetics Inc Director   –       •      –    2003-10-01 4 S $5.00 $125,100 I/I (25,000) 9,805 -
EXEL Exelixis Inc Director   –       •      –    2003-11-13 4 S $7.10 $106,497 I/I (15,000) 534,683 -
EXEL Exelixis Inc Director   –       •      –    2003-11-20 4 S $6.50 $16,250 I/I (2,500) 533,850 -
EXEL Exelixis Inc Director   –       •      –    2003-11-21 4 S $6.36 $79,503 I/I (12,500) 529,685 -
EXEL Exelixis Inc Director   –       •      –    2003-11-24 4 S $6.40 $704,462 I/I (110,000) 493,030 -
EXEL Exelixis Inc Director   –       •      –    2003-11-25 4 S $6.73 $253,566 I/I (37,700) 480,467 -
EXEL Exelixis Inc Director   –       •      –    2003-11-26 4 S $6.50 $161,947 I/I (24,900) 472,170 -
EXEL Exelixis Inc Director   –       •      –    2003-11-28 4 S $6.58 $658,160 I/I (100,000) 438,847 -
EXEL Exelixis Inc Director   –       •      –    2003-12-01 4 S $6.64 $2,059,547 I/I (310,000) 335,547 -
EXEL Exelixis Inc Director   –       •      –    2003-12-02 4 S $6.99 $628,758 I/I (90,000) 305,556 -
EXEL Exelixis Inc Director   –       •      –    2003-12-03 4 S $7.00 $142,759 I/I (20,400) 298,758 -
EXEL Exelixis Inc Director   –       •      –    2003-12-05 4 S $6.64 $29,230 I/I (4,400) 297,292 -
DCGN Decode Genetics Inc Director   –       •      –    2003-12-11 4 S $8.14 $159,570 I/I (19,610) 0 -
EXEL Exelixis Inc Director   –       •      –    2004-08-11 4 S $6.80 $1,360,000 I/I (200,000) 230,692 -
EXEL Exelixis Inc Director   –       •      –    2005-09-06 4 S $7.75 $1,550,240 I/I (200,000) 659,519 -
EXEL Exelixis Inc Director   –       •      –    2005-09-07 4 S $7.85 $588,750 I/I (75,000) 584,519 -
NXTM Nxstage Medical, Inc. Director   –       •       •   2005-10-27 4 B $10.00 $999,230 I/I 99,923 218,944 2.25 -
NXTM Nxstage Medical, Inc. Director   –       •       •   2005-11-01 4 A $0.00 $0 I/I 2,369,543 2,588,487 -
SGXP Sgx Pharmaceuticals, Inc. officerTitle   –       •       •   2006-02-01 4 B $6.00 $2,499,996 I/I 416,666 416,666 2.25 -
SGXP Sgx Pharmaceuticals, Inc. officerTitle   –       •       •   2006-02-06 4 A $0.00 $0 I/I 2,068,402 2,485,068 -
NXTM Nxstage Medical, Inc. Director   –       •       •   2006-05-26 4 D $10.95 $74,405 I/I (6,795) 2,592,126 -
  96  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us